Skip to main content

Day: May 9, 2022

Notice of Afarak Group Plc’s Annual General Meeting

08:00 London, 10:00 Helsinki, 9 May 2022 – Afarak Group Plc (LSE: AFRK, NASDAQ: AFAGR) Notice of Afarak Group Plc’s Annual General Meeting Notice is given to the shareholders of Afarak Group Plc (“Afarak”) of the Annual General Meeting to be held on 1 June 2022 at 2 p.m. the company´s headquarter, address Kaisaniemenkatu 4, 00100 Helsinki, Finland. The shareholders of the company may participate in the meeting and exercise their shareholder rights only by voting in advance or by way of proxy representation and by presenting counterproposals and asking questions in advance. It is not possible to attend the meeting in person. Instructions for shareholders can be found in part C of this Notice. The Board of Directors has resolved on exceptional meeting procedures based on the temporary legislation (375/2021) which entered into...

Continue reading

Automotive Fuel Cell Market Size to Hit USD 34.63 Billion by 2028 | Fuel Cell Industry Analysis by Share, Trends, And Growth Forecast

Automotive Fuel Cell Companies analyzed in report are Wystrach, UQM Technologies, Grove Hydrogen Automotive, FABER INDUSTRIE SPA, Danish Power Systems, Blue World Technologies, Foresight Energy, Bing Energy, Faurecia, Continental Industries, AVL, Nuvera Fuel Cells, Delphi Technologies, Toshiba, American Honda Motor Company, Inc., Nedstack Fuel Cell Technology, Toyota Motor Company, Ballard Power Systems, Wind2Gas Energy GmbH & Co KG, Umicore, Nissan Motor Corporation, Hyundai Motor CompanyAutomotive Fuel Cell Market Share Global Automotive Fuel Cell Market SharePune, India, May 09, 2022 (GLOBE NEWSWIRE) — The global automotive fuel cell market size is expected to grow from USD 1.73 billion in 2021 to USD 34.63 billion in 2028, according to a new report published by Fortune Business Insights. The global automotive fuel...

Continue reading

DSM: Final Results

Downing Strategic Micro-Cap Investment Trust plcLEI Code: 213800QMYPUW4POFFX699 May 2022Final Results The Directors of Downing Strategic Micro-Cap Investment Trust plc announce the company’s results for the year ended 28 February 2022. Key points5.3% increase in NAV and 1% increase in share price over 12 months to 28 Feb 2022, despite the volatility in markets due to post pandemic macro backdrop and the Ukraine conflict. Focused portfolio of actively managed investments with exciting catalysts now in play which should prove reliable in volatile markets. Investments have progressed through the ‘J curve’ and are now in either late-stage turnaround or growth phase. Investee companies are all well financed, and all are benefitting from a post covid environment. Significant return of capital in the year as well as interest and redemption...

Continue reading

Proactive news headlines including Orion Minerals, American Rare Earths, Dart Mining and SRJ Technologies Group

Sydney, May 09, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Orion Minerals Ltd (ASX:ORN, JSE:ORN) has inked non-binding term sheets for an US$87 million funding package that will advance its Prieska Copper-Zinc Mine in South Africa’s Northern Cape Province. Click here American Rare Earths Ltd (ASX:ARR) has confirmed the presence of a major rare earth deposit from its maiden exploration drill program at the Halleck Creek Rare Earths Project in Wyoming, USA. Click here Dart Mining NL (ASX:DTM) has appointed experienced company director Richard Udovenya as a non-executive director to its board, effective May 6. Click here SRJ Technologies Group PLC (ASX:SRJ) will deliver a large-scale bolt replacement campaign onboard...

Continue reading

Solar Thermal Market Size to Reach 767.73 GW by 2026 | Rise in Adoption of Clean Energy to Control Carbon Emissions Will Aid in Expansion of Global Solar Thermal Market

According to Fortune Business Insights, The global solar thermal market size stood at 496.15 GW in 2018 and is projected to reach 767.73 GW by 2026, exhibiting a CAGR of 5.6% during the forecast period.; Evacuated Tube Collectors Segment to Dominate Market with Operational Advantages, Predicts Fortune Business Insights™ Pune, India, May 09, 2022 (GLOBE NEWSWIRE) — The global solar thermal market size is prognosticated to rise exponentially owing to the rise in the use of solar power for various applications. A report on the market by Fortune Business Insights™ titled, “Solar Thermal Market Size, Share & Industry Analysis, By Collector Type (Evacuated Tube Collector, Flat Plate Collector, Unglazed Water Collector, Air Collector), By Type of System (Thermosiphon Solar Heating Systems, Pumped Solar Heating System) By Application...

Continue reading

Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations

COPENHAGEN, Denmark, May 9, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a new share buy-back program, under which the Company intends to buy back up to 71,562 of its own shares. The purpose of the share buy-back program is to meet the Company’s obligations arising from the share-based incentive programs for the Board of Directors and Executive Management, in accordance with the Company’s remuneration policy. The share buy-back program is initiated pursuant to the authorization granted at the annual general meeting on April 5, 2022, according to which the Company may purchase up to 10 % of the Company’s share capital for the time being. The share buy-back program will be executed in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse...

Continue reading

Bavarian Nordic Announces Interim Results for the First Three Months of 2022

COPENHAGEN, Denmark, May 9, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2022. Paul Chaplin, President & Chief Executive Officer of Bavarian Nordic said: “We have reported strong progress in our pipeline during the first quarter with additional Phase 2 results for our COVID-19 vaccine candidate, confirming its potential as a universal booster vaccine and we look forward to initiating the Phase 3 trial later this year. Furthermore, our RSV program was granted a Breakthrough Therapy Designation by the FDA, underlining the importance of the development of a vaccine to fulfil this high unmet medical need and to that end we initiated a Phase 3 program that will read out next year. In line with our RSV commercialization strategy, we were also pleased...

Continue reading

Arcadis partners with Wallbox on new 130,000 sq ft electric vehicle charger manufacturing facility in U.S. state of Texas

09 May, 2022 – Arcadis (EURONEXT: ARCAD) has been selected to manage the design and development program for Wallbox’s new electric vehicle (EV) charger manufacturing facility in Arlington, Texas, in the U.S. After a collaborative design process, Wallbox began construction of the 130,000 square foot facility in April. The plant will go into production in Q3 and is expected to produce 250,000 units in 2022. By 2025, the facility is expected to produce over 500,000 units annually. Wallbox’s chargers are compatible with all electric vehicles, making the new facility conducive to EV growth in the U.S. In addition to manufacturing, the site will also feature offices, labs, evaluation areas and a warehouse, and is expected to create 250 high-paying green jobs in the region. Ketan Maroo, vice president of industrial infrastructure at Arcadis,...

Continue reading

ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix for the Treatment of Uterine Fibroids at the 2022 ACOG Annual Clinical and Scientific Meeting

–Additional data from the PRIMROSE Phase 3 studies of linzagolix featured in four posters. Oral presentation took place on May 8, 2022 at 9:15am PT/12:15pm ET-GENEVA, Switzerland May 9, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced the presentation of clinical data from the PRIMROSE (1 and 2) Phase 3 studies of linzagolix for the treatment of heavy menstrual bleeding associated with uterine fibroids at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM), which was held in San Diego, California from May 6-8, 2022. “We are encouraged by these additional analyses and post-treatment data from the PRIMROSE Phase 3 study that continue to underscore linzagolix’s clinical...

Continue reading

Bone Therapeutics to host Annual General Meeting and Extraordinary General Meeting on 8 June 2022

REGULATED INFORMATIONPreliminary documents for the Annual and Extraordinary General Meeting have been made available on company’s websiteMont-Saint-Guibert, Belgium, 9 May 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics, invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the Annual General Meeting to be held on Wednesday 8 June 2022 as from 4:00 pm CEST, at Rue Granbonpré 11, Building H, 1435 Mont-Saint-Guibert, Belgium. Bone Therapeutics also invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the extraordinary general meeting which will be held on the same day as from 6:00 pm CEST, at Rue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.